Skip to content
Lower risk Medical device recall · FDA · Published May 13, 2021

Siemens Atellica IM 1300 Analyzer Recall: Valve Leaks Risk Test Accuracy

Siemens Healthcare recalls Atellica IM 1300 analyzers due to valve leaks that may cause inaccurate test results. Affected units have specific serial numbers and model ranges. Contact for repair or replacement.

🇺🇸 FDA recall #Z-2027-2021Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.511 Benedict Ave · Tarrytown, NY 10591-5005
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling Atellica IM 1300 analyzers because a manufacturing defect causes valves to leak over time. This leak can lead to inaccurate test results if the valve is exposed to high pressure or wear. Read more at govinfonow.com/recall/62545-siemens-atellica-im-1300-analyzer-recall-valve-leaks-risk-test.

Source Summary by GovInfoNow · govinfonow.com/recall/62545-siemens-atellica-im-1300-analyzer-recall-valve-leaks-risk-test · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2027-2021

Cite this page

“Siemens Atellica IM 1300 Analyzer Recall: Valve Leaks Risk Test Accuracy.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62545-siemens-atellica-im-1300-analyzer-recall-valve-leaks-risk-test. Based on FDA recall #Z-2027-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2027-2021%22&limit=1).

The FDA announced on May 13, 2021, that Siemens Healthcare Diagnostics, Inc. is recalling the Atellica IM 1300 Analyzer due to valves that may leak and impact assay result accuracy. This voluntary Class II recall affects units distributed nationwide and internationally.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Atellica IM 1300 Analyzer
  • SMN: 11066001
  • Serial Range: IM00873-IM01452 and IRM00256xxxx-IRM01169xxxx (where xxxx is any number)
  • UDI: 00630414007960

The hazard

Valves used on the Atellica CH 930, Atellica IM 1300 and Atellica IM 1600 analyzers may develop a malfunction due to a manufacturing defect. This can cause the valve to wear and leak over time, creating a risk in valves subject to high pressure or high wear that may impact the result accuracy of any assay.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics, Inc. has had 150 other recalls on record since June 7, 2017. Other recent recalls include the Siemens Atellica CH RCRP Test recall from August 17, 2026, and the Siemens Atellica CH Urine Albumin Recall from July 6, 2026. Similar recent recalls of other products include the Philips Integris-Allura System Recall (April 28, 2026), the On-X Mitral Heart Valve Recall (February 1, 2026), and the Baxter VOLARA System Recall (August 3, 2026).

How to tell if you have this one

Check for serial numbers starting with IM00873, IM01452, IRM00256xxxx, or IRM01169xxxx (where xxxx is any number). The UDI is 00630414007960.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide Foreign: Country Name Algeria Argentina Australia Austria Bahrain Bangladesh Belgium Brazil Bulgaria Burkina Faso Canada Chile Colombia Croatia Cura¿ao Cyprus Czech Republic Denmark Ecuador Egypt Estonia Finland France Germany Greece Hungary India Indonesia Iraq Ireland Israel Italy Japan Kenya Kuwait Latvia Libya Lithuania Malaysia Mexico Morocco Netherlands New Zealand Norway Oman P.R. China Pakistan Peru Philippines Poland Portugal Qatar Republic Korea Romania Russian Fed. Saudi Arabia Singapore Slovakia Slovenia South Africa Spain Sweden Switzerland Taiwan Thailand Turkey U.A.E. Uganda Ukraine United Kingdom Uruguay Vatikancity Vietnam
Recall numberProduct, codes & lotsQuantity
Z-2026-2021Atellica CH 930 Analyzer - multi-component system for in vitro diagnostic testing of clinical specimens SMN 11067000; Effected SN Range: CM00902 - CM02065 Note: xxxx in serial number is any number. UDI: 00630414002163US: 210 OUS: 874
Z-2027-2021Atellica IM 1300 Analyzer - multi-component system for in vitro diagnostic testing of clinical specimens SMN 11066001; Effected Serial Range: IM00873 IM01452 and IRM00256xxxx IRM01169xxxx Note: xxxx in serial number is any number. UDI: 00630414007960US: 233 OUS: 233
Z-2028-2021Atellica IM 1600 Analyzer- multi-component system for in vitro diagnostic testing of clinical specimens SMN 11066000; Effected serial range: IH00876 IH01451 and IRH00258xxxx IRH01169xxxx Note: xxxx in serial number is any number. UDI: 00630414002026US: 123 OUS: 751
Based on the official FDA remedy

What to do — step by step

  1. Check Serial Numbers

    Look for specific serial numbers in the affected ranges: IM00873, IM01452, IRM00256xxxx, or IRM01169xxxx (xxxx is any number).

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide Foreign: Country Name Algeria Argentina Australia Austria Bahrain Bangladesh Belgium Brazil Bulgaria Burkina Faso Canada Chile Colombia Croatia Cura¿ao Cyprus Czech Republic Denmark Ecuador Egypt Estonia Finland France Germany…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 2 months after the firm started it.

1. Firm started the recall: May 13, 202112. FDA classified it Class II: Jul 7, 202123. Published in FDA’s Enforcement Report: Jul 14, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2027-2021 (May 13, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2027-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA